229
Humacyte, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
154
FY23:
83.3
FY24:
47.9
FY25:
67.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
57.2
FY22:
50.1
FY23:
44.9
FY24:
90.0
FY25:
48.6
Total assets
Change from FY21 to FY25
millions USD
FY21:
287
FY22:
204
FY23:
128
FY24:
138
FY25:
116
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
11.1
FY22:
19.6
FY23:
18.4
FY24:
20.0
FY25:
18.4
(negative)
Change from FY21 to FY25
millions USD
FY21:
153
FY22:
67.8
FY23:
96.2
FY24:
171
FY25:
94.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
122
FY22:
117
FY23:
13.5
FY24:
−52.7
FY25:
3.11
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
287
FY22:
204
FY23:
128
FY24:
138
FY25:
116
All amounts in millions USD